Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 26, 2024 Filed Dec 27, 2024 22:57 UTC |
MOTT DAVID MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001628280-24-052533 · wk-form4_1735340223.xml · derivative · entry 2 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| December 26, 2024 Filed Dec 27, 2024 22:57 UTC |
MOTT DAVID MDirector
|
Exercise / conversionCommon Stock | 100,000 | $0.55 | $55,000.00 |
DisclosureSEC source: 0001628280-24-052533 · wk-form4_1735340223.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,738,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:59 UTC |
MOTT DAVID MDirector
|
PurchaseCommon Stock | 213,300 | $4.67 | $996,580.26 |
DisclosureSEC source: 0001628280-24-052363 · wk-form4_1734994751.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,638,765 F1 · price: Transaction was executed in multiple trades in prices ranging from $4.55 to $4.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| December 10, 2024 Filed Dec 13, 2024 00:02 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 520,000 Underlying: Common Stock · 25,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| December 10, 2024 Filed Dec 13, 2024 00:02 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 25,000 | $5.26 | $131,620.00 |
DisclosureSEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,150,385 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.22 to $5.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 13, 2024 00:02 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 25,000 | $0.99 | $24,750.00 |
DisclosureSEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,175,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| November 25, 2024 Filed Nov 28, 2024 01:15 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 25,000 | $5.38 | $134,482.50 |
DisclosureSEC source: 0001628280-24-049423 · wk-form4_1732756544.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,150,385 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.30 to $5.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:37 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 7,366 | $4.79 | $35,316.29 |
DisclosureSEC source: 0001628280-24-049057 · wk-form4_1732318656.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,745 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,371 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 18:22 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 4,941 | $4.79 | $23,689.62 |
DisclosureSEC source: 0001628280-24-049047 · wk-form4_1732317736.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,421 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 18:33 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 5,260 | $4.79 | $25,219.07 |
DisclosureSEC source: 0001628280-24-049053 · wk-form4_1732318388.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,139 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,142 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:34 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 2,243 | $4.79 | $10,754.06 |
DisclosureSEC source: 0001628280-24-049055 · wk-form4_1732318487.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 151,373 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:34 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 4,941 | $4.79 | $23,689.62 |
DisclosureSEC source: 0001628280-24-049055 · wk-form4_1732318487.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,005 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:31 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 31,980 | $4.79 | $153,328.11 |
DisclosureSEC source: 0001628280-24-049051 · wk-form4_1732318299.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175,385 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:24 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 7,046 | $4.79 | $33,782.05 |
DisclosureSEC source: 0001628280-24-049049 · wk-form4_1732317858.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,334 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:26 UTC |
MOTT DAVID MDirector
|
PurchaseCommon Stock | 215,868 | $4.62 | $996,597.80 |
DisclosureSEC source: 0001628280-24-047919 · wk-form4_1731619603.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425,465 F1 · price: Transaction was executed in multiple trades in prices ranging from $4.435 to $4.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:00 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 2,743 | $4.90 | $13,440.70 |
DisclosureSEC source: 0001628280-24-047271 · wk-form4_1731448844.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,207,365 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 23:00 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,171 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · derivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 0 Underlying: Common Stock · 27,171 shares Expires 2029-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 23:00 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 27,171 | $6.10 | $165,743.10 |
DisclosureSEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 153,616 F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 23:00 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionCommon Stock | 27,171 | $2.32 | $63,036.72 |
DisclosureSEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 180,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,172 | $2.32 Strike: $2.32 | $63,039.04 |
DisclosureSEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · derivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 27,171 Underlying: Common Stock · 27,172 shares Expires 2029-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 27,172 | $5.95 | $161,673.40 |
DisclosureSEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 153,616 F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionCommon Stock | 27,172 | $2.32 | $63,039.04 |
DisclosureSEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 180,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 12:24 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,000 Underlying: Common Stock · 25,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 12:24 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 25,000 | $5.91 | $147,740.00 |
DisclosureSEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,210,108 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.80 to $5.951, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 12:24 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 25,000 | $0.99 | $24,750.00 |
DisclosureSEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,235,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 21:01 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 7,500 | $6.01 | $45,075.00 |
DisclosureSEC source: 0001628280-24-042853 · wk-form4_1729026099.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,210,108 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| September 27, 2024 Filed Oct 1, 2024 20:34 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 49,564 | $6.92 | $342,982.88 |
DisclosureSEC source: 0001628280-24-041739 · wk-form4_1727814839.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,946 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024. Read SEC document |
| September 26, 2024 Filed Sep 27, 2024 20:09 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 3,000 | $6.07 | $18,210.00 |
DisclosureSEC source: 0001628280-24-041474 · wk-form4_1727467780.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,217,608 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 22:14 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 5,312 | $6.26 | $33,253.65 |
DisclosureSEC source: 0001628280-24-040556 · wk-form4_1726524865.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 153,616 F1 · price: Transaction was executed in multiple trades in prices ranging from $6.2601 to $6.265, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,676 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. F3 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:35 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,000 Underlying: Common Stock · 35,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:35 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 35,000 | $5.61 | $196,399.00 |
DisclosureSEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220,608 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F3 · price: Transaction was executed in multiple trades in prices ranging from $5.551 to $5.651, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:35 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 35,000 | $0.99 | $34,650.00 |
DisclosureSEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,255,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 21:45 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 7,500 | $6.22 | $46,635.00 |
DisclosureSEC source: 0001628280-24-038719 · wk-form4_1724881496.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,219,509 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: Transaction was executed in multiple trades in prices ranging from $6.161 to $6.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 20, 2024 Filed Aug 20, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,507 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · derivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Wife Disclosed balance after: 49,806 Underlying: Common Stock · 20,507 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. F3 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 20, 2024 Filed Aug 20, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 20,507 | $6.00 | $123,042.00 |
DisclosureSEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 3 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Wife Disclosed balance after: 158,502 F3 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 20, 2024 Filed Aug 20, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
Exercise / conversionCommon Stock | 20,507 | $0.99 | $20,301.93 |
DisclosureSEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Wife Disclosed balance after: 179,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:28 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 7,412 | $5.86 | $43,436.54 |
DisclosureSEC source: 0001628280-24-038296 · wk-form4_1724365676.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,740 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 18:20 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 4,969 | $5.86 | $29,119.83 |
DisclosureSEC source: 0001628280-24-038283 · wk-form4_1724365226.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,362 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 18:25 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 5,289 | $5.86 | $30,995.13 |
DisclosureSEC source: 0001628280-24-038291 · wk-form4_1724365500.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,257 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:26 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 2,250 | $5.86 | $13,185.68 |
DisclosureSEC source: 0001628280-24-038293 · wk-form4_1724365582.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 156,252 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:26 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 4,969 | $5.86 | $29,119.83 |
DisclosureSEC source: 0001628280-24-038293 · wk-form4_1724365582.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,510 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:24 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 32,225 | $5.86 | $188,848.17 |
DisclosureSEC source: 0001628280-24-038289 · wk-form4_1724365438.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,227,009 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:22 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 7,089 | $5.86 | $41,543.67 |
DisclosureSEC source: 0001628280-24-038287 · wk-form4_1724365356.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,380 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:21 UTC |
Felsch Robert OraSee Remarks
|
SaleCommon Stock | 3,567 | $5.86 | $20,903.69 |
DisclosureSEC source: 0001628280-24-038285 · wk-form4_1724365292.xml · nonDerivative · entry 1 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,560 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 22:59 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 20,000 | $5.94 | $118,740.00 |
DisclosureSEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 356,479 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.92 to $5.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 22:16 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 1,229 | $5.71 | $7,017.59 |
DisclosureSEC source: 0001628280-24-037315 · wk-form4_1723673808.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,259,234 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| August 08, 2024 Filed Aug 16, 2024 22:10 UTC |
Foster Eric DuaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $5.87 | $0.00 |
DisclosureSEC source: 0001628280-24-037607 · wk-form4_1723846234.xml · derivative · entry 2 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2034-08-08 F2 · derivative.exercise_date: Twenty Five Percent (25%) of the shares subject to the option vest on August 8, 2025 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| August 08, 2024 Filed Aug 16, 2024 22:10 UTC |
Foster Eric DuaneChief Commercial Officer
|
GrantCommon Stock | 180,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037607 · wk-form4_1723846234.xml · nonDerivative · entry 1 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 F1 · shares: Consists of 180,000 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 23:54 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-24-033836 · wk-form4_1722470059.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 605,000 Underlying: Common Stock · 30,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 23:54 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 30,000 | $5.64 | $169,314.00 |
DisclosureSEC source: 0001628280-24-033836 · wk-form4_1722470059.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,260,463 F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.61 to $5.695, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.